PAM SQUARED AT TEXARKANA — History
CCN 452061 | 3-year financial timeline | COVID resilience: 51/100
🛡️ Public data only — no PHI permitted on this instance.
$15M
Latest Revenue (FY2022)
-2.5%
Revenue CAGR (3yr)
14.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $16M | $15M | $15M | -3.4% | -2.5% |
| Operating Expenses | $14M | $14M | $13M | -5.8% | -4.1% |
| Operating Margin | 11.0% | 11.8% | 14.0% | +18.5% | +12.7% |
| Net Income | $2M | $2M | $2M | +14.5% | +9.9% |
| Licensed Beds | 30 | 30 | 30 | +0.0% | +0.0% |
| Total Patient Days | 7,949 | 7,888 | 7,821 | -0.8% | -0.8% |
| Medicare Day % | 78% | 72% | 85% | +17.3% | +4.5% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 51/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: -4.9% ($16M → $15M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
-2.5%
This Hospital
+7.6%
State Avg
Latest Margin
14.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $14M | 15.5% |
| FY2024 (proj) | $14M | 17.0% |
| FY2025 (proj) | $14M | 18.5% |